Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Comintell is a Swedish software company specializing in cloud-based intelligence solutions, primarily known for its flagship platform, Intelligence2day. The company provides competitive and market intelligence tools that are widely utilized by the life sciences, pharmaceutical, and healthcare industries to manage complex information environments. Its platform automates the collection and analysis of external data, including clinical trial news, regulatory updates, and competitor activities, to support strategic decision-making. By leveraging artificial intelligence and machine learning, Comintell helps organizations transform unstructured data into actionable insights and structured knowledge. In early 2024, Comintell was acquired by Valona Intelligence, a global leader in AI-powered market intelligence, to integrate its specialized capabilities into a broader insights ecosystem. The company remains a key technology partner for global R&D and commercial teams seeking to maintain a competitive edge in the rapidly evolving healthcare landscape.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Comintell.